Gary Titus
Director/Board Member at BioSight Ltd.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Cynthia Butitta | F | 70 | 7 years | |
| Fred Cohen | M | 67 | 7 years | |
| Stuart Holden | M | 82 | 9 years | |
| Pini Orbach | M | - |
BioSight Ltd.
 BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | 10 years |
| Aaron Sasson | M | - |
BioSight Ltd.
BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | 8 years |
| Christine Cassiano | F | - | 6 years | |
| James Ottinger | M | - | 7 years | |
| Ruth Ben-Yakar | M | 54 |
BioSight Ltd.
BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | 10 years |
| Mark Schoenberg | M | 66 | 8 years | |
| Gary Gordon | M | 71 |
BioSight Ltd.
BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | 4 years |
| Jeff Bova | M | - | 7 years | |
| Yuval Cabilliy | M | - |
BioSight Ltd.
BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hong Zhao | M | 60 | - | |
| Stephanie Wong | F | 50 |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 12 years |
| Ernest Mario | M | 85 |
IntraBiotics Pharmaceuticals, Inc.
 IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 1 years |
| Mark Gavin Lotter | M | 62 | 1 years | |
| Elias Bendekgey | M | 66 |
Nuvelo, Inc.
| 5 years |
| Elyse G. Seltzer | M | 59 | 6 years | |
| Stephen Mullennix | M | - | 2 years | |
| Min Yin | F | 53 | - | |
| Kathryn Falberg | F | 63 | 5 years | |
| Helen Kim | F | 61 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| Gregg Lapointe | M | 65 | 7 years | |
| Chaitan S. Khosla | M | 59 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 13 years |
| Trevor Jones | M | 82 | 3 years | |
| Peter Barrett | M | 71 | 2 years | |
| Ronald Bentsur | M | 58 | 4 years | |
| Jane M. Green | M | - |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| Simon Li | M | 74 | 4 years | |
| Thomas R. Parr | M | 70 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 1 years |
| Gregory S. Yedinak | M | - |
Nuvelo, Inc.
| 3 years |
| Jill M. Pergande | F | - |
Nuvelo, Inc.
| 3 years |
| Robert L. de Jager | M | 82 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| Israel Rios | M | 77 | 7 years | |
| David Myles | M | 62 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| Christopher T. Walsh | M | 80 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 12 years |
| Bill Burkoth | M | 47 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 2 years |
| Luis Peña | M | 61 |
Nuvelo, Inc.
| 4 years |
| S. Michael Imperiale | M | - |
Nuvelo, Inc.
| 3 years |
| Simon Allen | M | 56 |
Nuvelo, Inc.
| 2 years |
| Lan Xie | F | 51 | - | |
| Shelly Guyer | F | 63 |
Nuvelo, Inc.
| 1 years |
| Robert King | M | 60 | 6 years | |
| Chaim Hurvitz | M | 63 | 4 years | |
| Mark P. Joing | M | 52 |
Nuvelo, Inc.
| 5 years |
| Thamil Annamalai | F | - |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 4 years |
| Rick Allen | M | - |
BioCardia, Inc. /Old/
 BioCardia, Inc. /Old/ BiotechnologyHealth Technology BioCardia, Inc. is a clinical-stage regenerative medicine company developing novel therapeutics for cardiovascular diseases with large unmet medical needs. The firm develops two comprehensive biotherapeutic products for cardiac arrest; CardiAMP and CardiALLO. CardiAMP is a bone marrow derived cell-based therapy for ischemic systolic heart failure patients who are not actively ischemic. CardiALLo is a allogeneic culture expanded mesenchymal bone marrow cells from a universal donor for use in multiple unrelated patients, entering Phase II development. Its other products also include Helix System and Morph Products. The company was founded in March 2002 and is headquartered in San Carlos, CA. | - |
| Paul Chu | M | - | 1 years | |
| Jason Patel | M | - | - | |
| Steven R. Deitcher | M | 59 |
Nuvelo, Inc.
| 3 years |
| James R. Gavin | M | 78 |
Nuvelo, Inc.
| 3 years |
| Kim Popovits | F | 65 |
Nuvelo, Inc.
| 4 years |
| Charles Homcy | M | 75 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 5 years |
| Jan Johansson | M | - |
Nuvelo, Inc.
| 1 years |
| Barry Zubrow | M | 70 |
Nuvelo, Inc.
| 3 years |
| Steven Bryant Porter | M | 66 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 2 years |
| Williamson Z. Bradford | M | 62 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 3 years |
| Kevan E. Clemens | M | 80 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 3 years |
| Peter J. Licari | M | 60 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 10 years |
| David J. Loury | M | 68 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 5 years |
| Jonathan Wright | M | - |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 1 years |
| Roberto Camerini | M | 61 | 2 years | |
| Jie Jackie Guan | M | - | - | |
| Mark Perry | M | 68 |
Nuvelo, Inc.
| 6 years |
| George B. Rathmann | M | - |
Nuvelo, Inc.
| 6 years |
| Eric Bjerkholt | M | 64 |
IntraBiotics Pharmaceuticals, Inc.
IntraBiotics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology IntraBiotics, a developer of antibiotics and antifungals is focused on one drug candidate, iseganan hydrochloride oral solution, which would be used for the prevention of ventilator-associated pneumonia and to help cystic fibrosis patients fight respiratory infections. | 2 years |
| Henry Ward Wolff | M | 75 |
Nuvelo, Inc.
| 1 years |
| Burton E. Sobel | M | 86 |
Nuvelo, Inc.
| 5 years |
| Rolf H. Henel | M | 86 | 12 years | |
| Robert G. Johnson | M | 72 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 8 years |
| Thomas N. McCarter | M | 93 |
Nuvelo, Inc.
| 8 years |
| Peter García | M | 62 |
Nuvelo, Inc.
| 3 years |
| Martin Vogelbaum | M | 60 |
Nuvelo, Inc.
| 8 years |
| Michael D. Levy | M | 63 |
Nuvelo, Inc.
| 4 years |
| Linda Fitzpatrick | F | 67 |
Nuvelo, Inc.
| 4 years |
| Bruce Chabner | M | 83 |
Kosan Biosciences, Inc.
Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | 7 years |
| Hans P. Schmid | M | 72 | 10 years | |
| Scott Brown | M | 43 | 1 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 74 | 94.87% |
| Israel | 5 | 6.41% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Gary Titus
- Personal Network
